Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing Cohort Interim Data from Atopic Dermatitis ... Soquelitinib has been shown in preclinical studies to inhibit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback